Company intelligence
PHARMO Institute, part of Lumanity
About PHARMO Institute, part of Lumanity
The PHARMO Institute, part of Lumanity, uses data to derive real-life insights into value of medicines. We provide tailor-made research solutions for: post-authorization safety and efficacy (PASS, PAES) and drug utilization review (DUR); incidence/prevalence, treatment patterns, and patient pathways; comparative effectiveness, including synthetic control arms; healthcare resource use and cost of illness research; validation of surrogacy outcomes; as well as AI patient finding, classification, and disease progression prediction. Disease areas that are addressable in the PHARMO Data Network with ease include slow-progressing illnesses, conditions managed across primary and secondary care settings, and rare diseases where ICD-10 codes are often underutilized. PHARMO is a one-stop shop to coordinate your global observational research needs by leveraging its extensive data partner network and academic links to clinician/KOL experts. We also provide medical writing, scientific publications, and literature review services, as well as a host of strategic commercialization services with Lumanity.
Verified activity
Signals from PHARMO Institute, part of Lumanity
6 published signals
Research & Knowledge
PHARMO Institute, part of Lumanity published an article by Deborah Layton and Pav Rishiraj addressing the harmonization approach to drug safety science where Pharmacovigilance and Pharmacoepidemiology are complementary components of an integrated evidence system.
Reported by PHARMO Institute, part of Lumanity
Presence & Recognition
PHARMO Institute, part of Lumanity participated in the final day of the ICPE Annual 2026 meeting.
Reported by PHARMO Institute, part of Lumanity
Presence & Recognition
PHARMO Institute, part of Lumanity attended the International Society for Pharmacoepidemiology 2026 Congress program.
Reported by PHARMO Institute, part of Lumanity
Presence & Recognition
PHARMO Institute, part of Lumanity attended the ISPE Annual Meeting symposium titled From inception to reporting: the resources you need for flawless Target Trial Emulation.
Reported by PHARMO Institute, part of Lumanity
Presence & Recognition
PHARMO Institute, part of Lumanity participated in the ISPE Annual Conference in Milan.
Reported by PHARMO Institute, part of Lumanity
Presence & Recognition
PHARMO Institute, part of Lumanity is attending the International Society for Pharmacoepidemiology Annual Meeting in Milan.
Reported by PHARMO Institute, part of Lumanity